The incidence of blood clots linked to Johnson & Johnson’s (JNJ.N: Quote, Profile, Research) drug-coated stent Cypher are similar to those seen with competing artery-opening devices, U.S. regulators said on Tuesday.
The incidence of blood clots linked to Johnson & Johnson’s (JNJ.N: Quote, Profile, Research) drug-coated stent Cypher are similar to those seen with competing artery-opening devices, U.S. regulators said on Tuesday.